טוען...
Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application
Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second leading cause of cancer-related mortality within the next decade, with limited effective treatment options and a dismal long-term prognosis for patients. Genomic profiling has not yet manifested clinical benefits for diagnosis...
שמור ב:
| הוצא לאור ב: | Pancreatology |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Karger Publishers
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7994018/ https://ncbi.nlm.nih.gov/pubmed/33451936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pan.2020.12.017 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|